PKCζ as a promising therapeutic target for TNFα-induced inflammatory disorders in chronic cutaneous wounds
Authors:
Open Access
- 20 September 2017
- journal article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 40 (5) , 1335-1346
Abstract
Protein kinase Cζ (PKCζ) is a member of the atypical protein kinase C family. Its roles in macrophages or skin-resident keratinocytes have not been fully evaluated. In this study, we provide evidence that PKCζ mediates lipopolysaccharide (LPS)-induced tumor necrosis factor α (TNFα) gene expression in the mouse macrophage cell line, RAW264.7. TNFα has been proven to be one of the main culprits of chronic wounds and impaired acute wounds, which are characterized by excessive inflammation, enhanced proteolysis and reduced matrix deposition. Among the multiple effects of TNFα on keratinocytes, the induction of chemokines which are indispensable factors involved in the massive infiltration of various inflammatory cells into skin lesions serves as a crucial mechanism. In the present study, we found that PKCζ inhibitor or its specific siRNA inhibited the TNFα-induced upregulation in the levels of the chemokines, interleukin (IL)-8, monocyte chemotactic protein-1 (MCP-1) and intercellular cell adhesion molecule-1 (ICAM-1) in HaCaT keratinocytes. Moreover, under a disrupted inflammatory environment, activated keratinocytes can synthesize large amounts of matrix metalloproteinases (MMP), which has a negative effect on tissue remodeling. We discovered that TNFα promoted the expression of MMP9 in a PKCζ-dependent manner. Further experiments revealed that nuclear factor-κB (NF-κB) was a key downstream molecule of PKCζ. In addition, as shown in vitro, PKCζ was not involved in the TNFα-induced decrease in HaCaT cell migration and proliferation. In vivo experiments demonstrated that TNFα-induced wound closure impairment and inflammatory disorders were significantly attenuated in the PKCζ inhibitor group. On the whole, our findings suggest that PKCζ is a crucial regulator in LPS- or TNFα-induced inflammatory responses in RAW264.7 cells and HaCaT keratinocytes, and that PKCζ/NF-κB signaling may be a potential target for interventional therapy for TNFα-induced skin inflammatory injury.Keywords
This publication has 51 references indexed in Scilit:
- Protein Kinase C Zeta Regulates Human Pancreatic Cancer Cell Transformed Growth and Invasion through a STAT3-Dependent MechanismPLOS ONE, 2013
- Abnormal Cell Responses and Role of TNF-in Impaired Diabetic Wound HealingBioMed Research International, 2013
- The atypical PKCs in inflammation: NF‐κB and beyondImmunological Reviews, 2012
- HGF-Induced PKCζ Activation Increases Functional CXCR4 Expression in Human Breast Cancer CellsPLOS ONE, 2012
- PKCζ decreases eNOS protein stability via inhibitory phosphorylation of ERK5Blood, 2010
- TNF-α Signals Through PKCζ/NF-κB to Alter the Tight Junction Complex and Increase Retinal Endothelial Cell PermeabilityDiabetes, 2010
- Protein Kinase Cζ Mediates Cigarette Smoke/Aldehyde- and Lipopolysaccharide-induced Lung Inflammation and Histone ModificationsJournal of Biological Chemistry, 2010
- Matrix metalloproteinase-9 delays wound healing in a murine wound modelSurgery, 2010
- Activation of Keratinocyte Protein Kinase Cζ in Psoriasis PlaquesJournal of Investigative Dermatology, 2008
- Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetesBritish Journal of Dermatology, 2008